Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Switzerland

European Research Council grant · Running

PYROBOTS Magnetopyroelectric Biomedical Microrobots

Coordinator
Eidgenoessische Technische Hochschule Zuerich, Switzerland
Runs
1 January 2027 to 31 December 2031
Status
Running
EU funding
€2.5m
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101265732

What the project is doing

In the project's own words, from its summary on CORDIS.

Electrotherapies hold promise for diverse biomedical applications, including wound healing, pain relief, tissue regeneration, tumor ablation, inflammation reduction, and cell differentiation. However, current methods to deliver electric fields in the body often suffer from invasiveness, imprecise targeting and unintended side effects. To overcome these limitations, we propose PYROBOTS, a wireless microrobotic platform that leverages the magnetopyroelectric (MPE) effect to enable localized electrical stimulation without electrodes or internal power sources.

The MPE effect arises from coupling magnetic nanostructures, which generate heat under alternating magnetic fields, with pyroelectric components that convert thermal fluctuations into electricity. This approach will allow for fully wireless, tunable, and precise electrostimulation. Drawing on expertise in nanomanufacturing, microrobotics, and magnetic actuation, PYROBOTS offers a minimally invasive, multifunctional nanosystem for targeted electrotherapies in anatomically constrained and clinically challenging environments.

The ultimate goal of PYROBOTS is to demonstrate that small-scale microrobotic swarms built from MPE nanostructures can safely deliver electrotherapies within the sensitive neural environment of the spine. To explore the full therapeutic potential and boundaries of this approach, we will target two distinct clinical contexts: (1) spinal cord injury, using MPE-functionalized neuronal progenitor cells to promote neuronal differentiation and regeneration, and (2) spinal cord glioblastoma, using synthetic MPE nanoparticle swarms to induce electroporation and immune activation.

Topics

Who is involved

OrganisationCityCountryRole
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI